147 related articles for article (PubMed ID: 14673901)
1. Paraneoplastic movement disorder in a patient with non-Hodgkin's lymphoma and CRMP-5 autoantibody.
Samii A; Dahlen DD; Spence AM; Maronian NC; Kraus EE; Lennon VA
Mov Disord; 2003 Dec; 18(12):1556-8. PubMed ID: 14673901
[TBL] [Abstract][Full Text] [Related]
2. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.
Yu Z; Kryzer TJ; Griesmann GE; Kim K; Benarroch EE; Lennon VA
Ann Neurol; 2001 Feb; 49(2):146-54. PubMed ID: 11220734
[TBL] [Abstract][Full Text] [Related]
3. Rituximab immunotherapy for non-Hodgkin's lymphoma.
White CA
Cancer Biother Radiopharm; 1999 Aug; 14(4):241-50. PubMed ID: 10850310
[TBL] [Abstract][Full Text] [Related]
4. Double trouble: para-neoplastic anti-PCA-2 and CRMP-5-mediated small fibre neuropathy followed by chorea associated with small cell lung cancer and evolving radiological features.
Waheed W; Boyd J; Khan F; Mount SL; Borden NM; Tandan R
BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27571910
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.
Cross SA; Salomao DR; Parisi JE; Kryzer TJ; Bradley EA; Mines JA; Lam BL; Lennon VA
Ann Neurol; 2003 Jul; 54(1):38-50. PubMed ID: 12838519
[TBL] [Abstract][Full Text] [Related]
6. Hemichorea in a thymoma patient without anti-CRMP-5 antibody.
Nakae Y; Ikeda S; Yamamoto R; Tanaka F; Johkura K
Neurol Sci; 2014 Apr; 35(4):629-30. PubMed ID: 24413817
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic limbic encephalitis (PLE) and chorea associated with CRMP-5 neuronal antibody.
Kinirons P; Fulton A; Keoghan M; Brennan P; Farrell MA; Moroney JT
Neurology; 2003 Dec; 61(11):1623-4. PubMed ID: 14663059
[No Abstract] [Full Text] [Related]
8. Rituximab: active treatment of central nervous system involvement by non-Hodgkin's lymphoma?
Ruhstaller TW; Amsler U; Cerny T
Ann Oncol; 2000 Mar; 11(3):374-5. PubMed ID: 10811510
[No Abstract] [Full Text] [Related]
9. [Monoclonal antibody therapy for non-Hodgkin's lymphoma].
Paul F; Rossi JF; Cartron G
Rev Prat; 2010 Jan; 60(1):59-63. PubMed ID: 20222313
[TBL] [Abstract][Full Text] [Related]
10. [Auto-immune manifestations in Non-Hodgkin's lymphoma].
Jardin F; Lévesque H; Tilly H
Rev Med Interne; 2005 Jul; 26(7):557-71. PubMed ID: 15996570
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.
Vernino S; Tuite P; Adler CH; Meschia JF; Boeve BF; Boasberg P; Parisi JE; Lennon VA
Ann Neurol; 2002 May; 51(5):625-30. PubMed ID: 12112110
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal antibody immunotherapy for malignant non-Hodgkin's lymphoma].
Jourdan E; Richard B
Presse Med; 2000 Apr; 29(13):717-21. PubMed ID: 10797826
[TBL] [Abstract][Full Text] [Related]
13. Evolving role of rituximab in the treatment of patients with non-Hodgkin's lymphoma.
Traullé C; Coiffier BB
Future Oncol; 2005 Jun; 1(3):297-306. PubMed ID: 16556002
[TBL] [Abstract][Full Text] [Related]
14. Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma.
Bauduer F
Br J Haematol; 2001 Mar; 112(4):1085-6. PubMed ID: 11324638
[No Abstract] [Full Text] [Related]
15. Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation.
Pan D; Moskowitz CH; Zelenetz AD; Straus D; Kewalaramani T; Noy A; Qin J; Teruya-Feldstein J; Portlock CS
Cancer J; 2002; 8(5):371-6. PubMed ID: 12416894
[TBL] [Abstract][Full Text] [Related]
16. Antibody therapy for non-Hodgkin's lymphoma.
Ansell SM
Curr Opin Mol Ther; 2004 Apr; 6(2):175-81. PubMed ID: 15195930
[TBL] [Abstract][Full Text] [Related]
17. Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma: interim follow-up of a multicenter phase II trial.
Hainsworth JD
Semin Oncol; 2002 Feb; 29(1 Suppl 2):25-9. PubMed ID: 11842385
[TBL] [Abstract][Full Text] [Related]
18. Novel antibodies in the treatment of non-Hodgkin's lymphoma.
Bhat SA; Czuczman MS
Neth J Med; 2009 Sep; 67(8):311-21. PubMed ID: 19767657
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's and non-Hodgkin's lymphomas.
Rademaker J
Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
[TBL] [Abstract][Full Text] [Related]
20. New approaches to the management of Non-Hodgkin's lymphoma.
Estes J
Semin Oncol Nurs; 2002 Feb; 18(1 Suppl 1):1-2. PubMed ID: 11878045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
